NO943327L - Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol - Google Patents

Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Info

Publication number
NO943327L
NO943327L NO943327A NO943327A NO943327L NO 943327 L NO943327 L NO 943327L NO 943327 A NO943327 A NO 943327A NO 943327 A NO943327 A NO 943327A NO 943327 L NO943327 L NO 943327L
Authority
NO
Norway
Prior art keywords
cells
cytosol
introducing molecules
photochemical method
photodynamic treatment
Prior art date
Application number
NO943327A
Other languages
English (en)
Other versions
NO180167B (no
NO943327D0 (no
NO180167C (no
Inventor
Kristian Berg
Johan Moan
Kirsten Sandvig
Original Assignee
Radiumhospitalets Forskningsst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Radiumhospitalets Forskningsst filed Critical Radiumhospitalets Forskningsst
Priority to NO943327A priority Critical patent/NO180167C/no
Publication of NO943327D0 publication Critical patent/NO943327D0/no
Priority to CNB951960652A priority patent/CN1222309C/zh
Priority to EP95932244A priority patent/EP0783323B1/en
Priority to JP50940496A priority patent/JP4148328B2/ja
Priority to ES95932244T priority patent/ES2163527T3/es
Priority to PCT/NO1995/000149 priority patent/WO1996007432A1/en
Priority to NZ509519A priority patent/NZ509519A/en
Priority to AT95932244T priority patent/ATE209507T1/de
Priority to NZ293008A priority patent/NZ293008A/en
Priority to PT95932244T priority patent/PT783323E/pt
Priority to HU9800153A priority patent/HU222984B1/hu
Priority to US08/793,794 priority patent/US5876989A/en
Priority to MX9701676A priority patent/MX9701676A/es
Priority to BRPI9508825A priority patent/BRPI9508825B8/pt
Priority to AU35347/95A priority patent/AU700797B2/en
Priority to CZ97658A priority patent/CZ65897A3/cs
Priority to CA2199290A priority patent/CA2199290C/en
Priority to DE69524238T priority patent/DE69524238T2/de
Priority to KR10-2003-7005142A priority patent/KR100529967B1/ko
Priority to KR1019970701520A priority patent/KR100395615B1/ko
Publication of NO943327L publication Critical patent/NO943327L/no
Publication of NO180167B publication Critical patent/NO180167B/no
Publication of NO180167C publication Critical patent/NO180167C/no
Priority to FI970983A priority patent/FI121328B/fi
Priority to HK98103468A priority patent/HK1004110A1/xx
Priority to US09/144,750 priority patent/US6680301B2/en
Priority to US10/286,632 priority patent/US20030134813A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0071—PDT with porphyrins having exactly 20 ring atoms, i.e. based on the non-expanded tetrapyrrolic ring system, e.g. bacteriochlorin, chlorin-e6, or phthalocyanines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
NO943327A 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol NO180167C (no)

Priority Applications (24)

Application Number Priority Date Filing Date Title
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
DE69524238T DE69524238T2 (de) 1994-09-08 1995-09-04 Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen
MX9701676A MX9701676A (es) 1994-09-08 1995-09-04 Transferencia de moleculas al citosol de celulas.
AU35347/95A AU700797B2 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
JP50940496A JP4148328B2 (ja) 1994-09-08 1995-09-04 細胞サイトゾルへの化合物の移入
ES95932244T ES2163527T3 (es) 1994-09-08 1995-09-04 Transferencia de moleculas hacia el interior del citosol de las celulas por medio de sustancias fotosensibilizadoras.
PCT/NO1995/000149 WO1996007432A1 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
NZ509519A NZ509519A (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
AT95932244T ATE209507T1 (de) 1994-09-08 1995-09-04 Transfer von molekülen in das zytosol von zellen durch photosensibilisierende substanzen
NZ293008A NZ293008A (en) 1994-09-08 1995-09-04 Photoactivatable compound-carrier molecule conjugates for transfer into a cell cytosol where they are taken up by endosomes and lysosomes
PT95932244T PT783323E (pt) 1994-09-08 1995-09-04 Transferencia de moleculas para o citosol de celulas por meio de compostos fotossensibilizantes
HU9800153A HU222984B1 (hu) 1994-09-08 1995-09-04 Eljárás molekulák in vitro bevezetésére élő sejtek citoszoljába, fotoszenzibilizáló vegyület alkalmazásával
US08/793,794 US5876989A (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
CNB951960652A CN1222309C (zh) 1994-09-08 1995-09-04 将分子导入细胞溶质
BRPI9508825A BRPI9508825B8 (pt) 1994-09-08 1995-09-04 processo de transferência de moléculas para o citosol de células, composição e kit
EP95932244A EP0783323B1 (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells by photosensitizing compounds
CZ97658A CZ65897A3 (en) 1994-09-08 1995-09-04 Method of transferring molecules into cytosol of cells, set for making the method and a mixture for modification neoplastic or other cellular processes
CA2199290A CA2199290C (en) 1994-09-08 1995-09-04 Transfer of molecules into the cytosol of cells
KR1019970701520A KR100395615B1 (ko) 1994-09-08 1995-09-14 세포의시토졸내로분자를전달시키는방법
KR10-2003-7005142A KR100529967B1 (ko) 1994-09-08 1995-09-14 세포의 시토졸내로 분자를 전달시키는 조성물
FI970983A FI121328B (fi) 1994-09-08 1997-03-07 Molekyylien siirto solujen sytosoliin
HK98103468A HK1004110A1 (en) 1994-09-08 1998-04-24 Transfer of molecules into the cytosol of cells
US09/144,750 US6680301B2 (en) 1994-09-08 1998-09-01 Transfer of molecules into the cytosol of cells
US10/286,632 US20030134813A1 (en) 1994-09-08 2002-11-01 Transfer of molecules into the cytosol of cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Publications (4)

Publication Number Publication Date
NO943327D0 NO943327D0 (no) 1994-09-08
NO943327L true NO943327L (no) 1996-03-11
NO180167B NO180167B (no) 1996-11-18
NO180167C NO180167C (no) 1997-02-26

Family

ID=19897382

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943327A NO180167C (no) 1994-09-08 1994-09-08 Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol

Country Status (20)

Country Link
US (3) US5876989A (no)
EP (1) EP0783323B1 (no)
JP (1) JP4148328B2 (no)
KR (2) KR100395615B1 (no)
CN (1) CN1222309C (no)
AT (1) ATE209507T1 (no)
AU (1) AU700797B2 (no)
BR (1) BRPI9508825B8 (no)
CA (1) CA2199290C (no)
CZ (1) CZ65897A3 (no)
DE (1) DE69524238T2 (no)
ES (1) ES2163527T3 (no)
FI (1) FI121328B (no)
HK (1) HK1004110A1 (no)
HU (1) HU222984B1 (no)
MX (1) MX9701676A (no)
NO (1) NO180167C (no)
NZ (2) NZ293008A (no)
PT (1) PT783323E (no)
WO (1) WO1996007432A1 (no)

Families Citing this family (81)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US6210356B1 (en) * 1998-08-05 2001-04-03 Ekos Corporation Ultrasound assembly for use with a catheter
US6176842B1 (en) * 1995-03-08 2001-01-23 Ekos Corporation Ultrasound assembly for use with light activated drugs
DE69840046D1 (de) * 1997-03-19 2008-11-06 Lucid Inc Zellchirurgie unter benutzung konfokaler mikroskopie
US6582392B1 (en) 1998-05-01 2003-06-24 Ekos Corporation Ultrasound assembly for use with a catheter
US6676626B1 (en) 1998-05-01 2004-01-13 Ekos Corporation Ultrasound assembly with increased efficacy
US6835393B2 (en) * 1998-01-05 2004-12-28 University Of Washington Enhanced transport using membrane disruptive agents
US6399769B1 (en) * 1998-01-20 2002-06-04 Kimberly-Clark Worldwide, Inc. Method of making sulfanatophenyl substituted porphines
GB9905911D0 (en) * 1999-03-15 1999-05-05 Photocure As Method
WO2001019953A1 (fr) * 1999-09-09 2001-03-22 Center For Advanced Science And Technology Incubation, Ltd. Procede de perçage de membrane et appareil a cet effet
US20040220100A1 (en) * 2000-07-21 2004-11-04 Essentia Biosystems, Inc. Multi-component biological transport systems
CA2797652C (en) * 2000-07-21 2016-03-08 Revance Therapeutics, Inc. Multi-component biological transport systems
BR0115795A (pt) * 2000-11-29 2003-08-12 Pci Biotech As Métodos para introduzir uma molécula no citosol de uma célula, para o tratamento ou prevenção de uma doença, distúrbio ou infecção em um paciente, para estimular uma resposta imune, célula, e, uso de uma molécula de transferência e/ou um agente fotossensibilizante
CN100490902C (zh) * 2000-11-29 2009-05-27 Pci生物技术联合股份有限公司 病毒介导的分子传递进入胞质溶胶的光化学内在化
US20020098472A1 (en) * 2000-11-30 2002-07-25 Erlach Julian Van Method for inserting a microdevice or a nanodevice into a body fluid stream
US20020137901A1 (en) * 2001-01-22 2002-09-26 Cavanaugh Philip Gerard Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
AU2002250034A1 (en) * 2001-02-08 2002-08-19 Sequitur, Inc. Methods of light activated release 0f ligands from endosomes
PT1407787E (pt) * 2001-06-20 2009-07-07 Koken Kk Método de promoção da transferência de ácido nucleico
GB0121023D0 (en) 2001-08-30 2001-10-24 Norwegian Radium Hospital Res Compound
WO2003047439A2 (en) 2001-12-03 2003-06-12 Ekos Corporation Catheter with multiple ultrasound radiating members
US7141044B2 (en) 2001-12-11 2006-11-28 Ekos Corporation Alternate site gene therapy
EP1572902B1 (en) * 2002-02-01 2014-06-11 Life Technologies Corporation HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
US20060009409A1 (en) * 2002-02-01 2006-01-12 Woolf Tod M Double-stranded oligonucleotides
DE60337040D1 (de) 2002-02-01 2011-06-16 Life Technologies Corp Oligonukleotid-Zusammensetzungen mit verbesserter Wirksamkeit
US8226629B1 (en) 2002-04-01 2012-07-24 Ekos Corporation Ultrasonic catheter power control
US20040248094A1 (en) * 2002-06-12 2004-12-09 Ford Lance P. Methods and compositions relating to labeled RNA molecules that reduce gene expression
GB0215534D0 (en) * 2002-07-04 2002-08-14 Ecole Polytech Selective photochemotherapy using oligonucleotide targeting agents
US20040029275A1 (en) * 2002-08-10 2004-02-12 David Brown Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
US6921371B2 (en) * 2002-10-14 2005-07-26 Ekos Corporation Ultrasound radiating members for catheter
WO2004063342A2 (en) * 2003-01-09 2004-07-29 Invitrogen Corporation Cellular delivery and activation polypeptide-nucleic acid complexes
US7332477B2 (en) * 2003-07-10 2008-02-19 Nitto Denko Corporation Photocleavable DNA transfer agent
DE602004026747D1 (de) * 2003-09-29 2010-06-02 Nitto Denko Corp Biologisch abbaubare polyacetale für die in-vivo-abgabe von polynucleotiden
JP4954550B2 (ja) * 2003-12-19 2012-06-20 大日本住友製薬株式会社 新規な核酸導入法
BRPI0508440A (pt) 2004-03-03 2007-07-24 Revance Therapeutics Inc composições e métodos para diagnóstico tópico e transporte terapêutico
KR101322433B1 (ko) * 2004-03-03 2013-10-28 레반스 테라퓨틱스, 아이엔씨. 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
GB0415263D0 (en) * 2004-07-07 2004-08-11 Norwegian Radium Hospital Res Method
US20060094781A1 (en) * 2004-11-04 2006-05-04 Syneron Medical Ltd. Method of treating extracellular matrix
FR2877943B1 (fr) * 2004-11-16 2008-09-05 Univ De Coimbra Nouveaux derives de porphyrine, notamment chlorines et/ou bacteriochlorine, et leurs applications en therapie photodynamique
CA2599016A1 (en) * 2005-03-03 2006-09-08 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of an oligopeptide
KR101453963B1 (ko) 2005-03-03 2014-10-22 레반스 테라퓨틱스, 아이엔씨. 보툴리눔 독소의 국소 적용 및 경피 전달을 위한 조성물 및 방법
US7674452B2 (en) * 2005-03-16 2010-03-09 Nitto Denko Corporation Polymer coating of cells
BRPI0501037B8 (pt) 2005-03-18 2021-07-27 Fund De Amparo A Pesquisa Do Estado De Sao Paulo uso de crotamina e composição
US8518414B2 (en) * 2005-11-17 2013-08-27 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
WO2007109584A1 (en) * 2006-03-16 2007-09-27 University Of Washington Temperature-and ph-responsive polymer compositions
GB0613753D0 (en) 2006-07-11 2006-08-23 Norwegian Radium Hospital Res Method
EP2099496A2 (en) * 2006-12-08 2009-09-16 Massachusetts Institute of Technology Delivery of nanoparticles and/or agents to cells
WO2008082889A2 (en) * 2006-12-29 2008-07-10 Revance Therapeutics, Inc. Compositions and methods of topical application and transdermal delivery of botulinum toxins stabilized with polypeptide fragments derived from hiv-tat
JP2010514779A (ja) * 2006-12-29 2010-05-06 ルバンス セラピュティックス インク． 逆配列ｈｉｖ−ｔａｔポリペプチドを用いる輸送分子
US10182833B2 (en) 2007-01-08 2019-01-22 Ekos Corporation Power parameters for ultrasonic catheter
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
EP2170181B1 (en) 2007-06-22 2014-04-16 Ekos Corporation Method and apparatus for treatment of intracranial hemorrhages
WO2009079415A1 (en) * 2007-12-14 2009-06-25 Ekos Corporation Ultrasound pulse shaping
GB0811955D0 (en) 2008-06-30 2008-07-30 Pci Biotech As Method
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
GB201208548D0 (en) 2012-05-15 2012-06-27 Pci Biotech As Compound and method
WO2014139597A1 (en) 2013-03-15 2014-09-18 Pci Biotech As Method
AU2014314149B2 (en) 2013-08-28 2019-12-19 Pci Biotech As Compound and method for vaccination and immunisation
GB2517707B (en) 2013-08-28 2020-09-02 Pci Biotech As A device for light-induced rupture of endocytic vesicles to effect the delivery of an antigen
AU2014390262B2 (en) 2014-04-11 2020-11-26 Pci Biotech As Method of treating melanoma
EP3185901B1 (en) 2014-08-28 2023-10-04 PCI Biotech AS Compound and method
GB201503776D0 (en) 2015-03-05 2015-04-22 Pci Biotech As Compound and method
US10656025B2 (en) 2015-06-10 2020-05-19 Ekos Corporation Ultrasound catheter
CN110022874A (zh) 2016-10-14 2019-07-16 Pci生物技术有限公司 以tpcs-2a诱导的吉西他滨光化学内在化治疗胆管癌
GB201718631D0 (en) 2017-11-10 2017-12-27 Pci Biotech As Method
GB201801169D0 (en) * 2018-01-24 2018-03-07 Pci Biotech As Method
EP3823668A1 (en) 2018-07-16 2021-05-26 DCPrime B.V. A combination product for use in tumor vaccination
WO2020217226A1 (en) 2019-04-25 2020-10-29 Dcprime B.V. Methods of tumor vaccination
CN110711249B (zh) * 2019-09-19 2020-10-27 北京化工大学 一种溶酶体膜包覆纳米颗粒的制备方法
AU2021244937A1 (en) 2020-03-27 2022-11-03 Mendus B.V. In vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
WO2021191870A1 (en) 2020-03-27 2021-09-30 Dcprime B.V. Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
CN114163508A (zh) * 2020-09-11 2022-03-11 王月志 能破坏细胞的氨基酸序列及相关核苷酸序列和相关的应用
EP4240405A1 (en) 2020-11-05 2023-09-13 Mendus B.V. Use of tumor-independent antigens in immunotherapies
GB202101726D0 (en) 2021-02-08 2021-03-24 Pci Biotech As Method
JP2024510989A (ja) 2021-03-12 2024-03-12 メンドゥス・ベスローテン・フェンノートシャップ ワクチン接種方法及びｃｄ４７遮断薬の使用
GB202115451D0 (en) 2021-10-27 2021-12-08 Pci Biotech As Method
WO2024068795A1 (en) 2022-09-27 2024-04-04 Pci Biotech As Method for releasing viral vectors

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU563827B2 (en) 1982-07-01 1987-07-23 Millipore Corp. Filtration apparatus
US4649151A (en) * 1982-09-27 1987-03-10 Health Research, Inc. Drugs comprising porphyrins
US4704255A (en) 1983-07-15 1987-11-03 Pandex Laboratories, Inc. Assay cartridge
US5066274A (en) * 1985-04-30 1991-11-19 Nippon Petrochemicals Company, Ltd. Tetrapyrrole therapeutic agents
US5076950A (en) 1985-12-20 1991-12-31 Syntex (U.S.A.) Inc. Magnetic composition for particle separation
US4895706A (en) 1986-10-28 1990-01-23 Costar Corporation Multi-well filter strip and composite assemblies
US5095030A (en) * 1987-01-20 1992-03-10 University Of British Columbia Wavelength-specific cytotoxic agents
NO891491L (no) * 1987-08-12 1989-04-11 Peter Nemeth Prosedyre for befrielse av celleblandinger og vev for uoenskede populasjoner.
HU204856B (en) 1987-08-12 1992-02-28 Orszagos Mueszaki Fejlesztesi Process for releasing cell mixtures and tissues from undesired populations and for producing monoclonal antibody - hematoporphyrin conjugates
GB8721108D0 (en) * 1987-09-08 1987-10-14 Salford University Of Liposomes
US5284647A (en) * 1988-03-18 1994-02-08 Schering Aktiengesellschaft Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them
US5256532A (en) 1988-05-02 1993-10-26 Zynaxis Technologies, Inc. Methods, reagents and test kits for determination of subpopulations of biological entities
US4925736A (en) * 1988-07-06 1990-05-15 Long Island Jewish Medical Center Topical hematoporphyrin
GB8905001D0 (en) 1989-03-04 1989-04-19 Univ Leicester Screening for natural products of microbial metabolism
US4935498A (en) * 1989-03-06 1990-06-19 Board Of Regents, The University Of Texas System Expanded porphyrins: large porphyrin-like tripyrroledimethine-derived macrocycles
US5567687A (en) * 1989-03-06 1996-10-22 University Of Texas Texaphyrins and uses thereof
US5328470A (en) * 1989-03-31 1994-07-12 The Regents Of The University Of Michigan Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor
US5059619A (en) * 1989-06-14 1991-10-22 Quadra Logic Technologies, Inc. Stable freeze-dried polyhematoporphyrin ether/ester
DE3919873A1 (de) 1989-06-19 1990-12-20 Behringwerke Ag Magnetische protein-konjugate, verfahren zu ihrer herstellung und ihre verwendung
GB8916859D0 (en) 1989-07-24 1989-09-06 Dynal As Hapten linking
GB8929297D0 (en) 1989-12-29 1990-02-28 Dynal As Method of separation
US5200084A (en) 1990-09-26 1993-04-06 Immunicon Corporation Apparatus and methods for magnetic separation
US5491068A (en) 1991-02-14 1996-02-13 Vicam, L.P. Assay method for detecting the presence of bacteria
US5179120A (en) * 1991-06-28 1993-01-12 Cytopharm, Inc. Porphycene compounds for photodynamic therapy
PL165249B1 (pl) * 1991-10-29 1994-11-30 Wojskowa Akad Tech Sposób otrzymywania soli kompleksowych hematoporfiryny i jej pochodnych PL PL PL PL PL PL PL
US5376546A (en) * 1991-11-04 1994-12-27 Xoma Corporation Analogs of ribosome-inactivating proteins
US5258453A (en) * 1992-01-21 1993-11-02 University Of Utah Drug delivery system for the simultaneous delivery of drugs activatable by enzymes and light
DK0672180T3 (da) * 1992-03-16 2002-03-04 Isis Pharmaceuticals Inc Oligonukleotidmodulering af protein kinase C
JPH07509120A (ja) 1992-03-20 1995-10-12 セルシス・インターナショナル・パブリック・リミテッド・カンパニー 生物学的物質の分析方法およびその装置
JPH07506252A (ja) * 1992-04-24 1995-07-13 エス・アール・アイ・インターナシヨナル 真核細胞内でのイン・ビボ相同配列ターゲッティング
AU2593192A (en) 1992-09-14 1994-04-12 Oystein Fodstad Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
CA2148368A1 (en) * 1992-11-03 1994-05-11 Mouldy Sioud Tnf-.alpha. ribozymes and degradation resistant mrna derivatives linked to tnf-.alpha. ribozymes
FR2700010B1 (fr) 1992-12-24 1995-03-17 Rocher Yves Biolog Vegetale Méthode et dispositif pour tester la réactivité de cellules à l'égard de produits.
US5374531A (en) 1993-03-22 1994-12-20 Zynaxis, Inc. Immunoassay for determination of cells
US5861310A (en) * 1993-11-03 1999-01-19 Dana-Farber Cancer Institute Tumor cells modified to express B7-2 with increased immunogenicity and uses therefor
US5491084A (en) * 1993-09-10 1996-02-13 The Trustees Of Columbia University In The City Of New York Uses of green-fluorescent protein
US6015897A (en) * 1993-12-07 2000-01-18 Neorx Corporation Biotinamido-n-methylglycyl-seryl-o-succinamido-benzyl dota
US5514340A (en) 1994-01-24 1996-05-07 Magnetix Biotechnology, Inc. Device for separating magnetically labelled cells
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
NO180167C (no) * 1994-09-08 1997-02-26 Photocure As Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
US5872007A (en) * 1995-02-17 1999-02-16 Hybridon, Inc. CAPL-specific oligonucleotides and methods of inhibiting metastatic cancer

Also Published As

Publication number Publication date
US20030134813A1 (en) 2003-07-17
CN1222309C (zh) 2005-10-12
AU700797B2 (en) 1999-01-14
ES2163527T3 (es) 2002-02-01
BR9508825A (pt) 1998-01-06
EP0783323A1 (en) 1997-07-16
FI970983A (fi) 1997-03-07
FI970983A0 (fi) 1997-03-07
NO180167B (no) 1996-11-18
NO943327D0 (no) 1994-09-08
EP0783323B1 (en) 2001-11-28
HUT77469A (hu) 1998-05-28
US20020155099A1 (en) 2002-10-24
US6680301B2 (en) 2004-01-20
JP4148328B2 (ja) 2008-09-10
CN1164829A (zh) 1997-11-12
HU222984B1 (hu) 2004-01-28
NZ509519A (en) 2004-10-29
BRPI9508825B8 (pt) 2021-07-06
US5876989A (en) 1999-03-02
CA2199290C (en) 2010-10-26
KR100529967B1 (ko) 2005-11-22
DE69524238D1 (de) 2002-01-10
JPH10508295A (ja) 1998-08-18
FI121328B (fi) 2010-10-15
KR100395615B1 (ko) 2003-12-31
BRPI9508825B1 (pt) 2020-12-22
NZ293008A (en) 2001-04-27
WO1996007432A1 (en) 1996-03-14
DE69524238T2 (de) 2002-07-18
NO180167C (no) 1997-02-26
CA2199290A1 (en) 1996-03-14
KR20040004402A (ko) 2004-01-13
KR970705415A (ko) 1997-10-09
CZ65897A3 (en) 1997-10-15
MX9701676A (es) 1998-04-30
AU3534795A (en) 1996-03-27
PT783323E (pt) 2002-03-28
ATE209507T1 (de) 2001-12-15
HK1004110A1 (en) 1998-11-20

Similar Documents

Publication Publication Date Title
NO943327L (no) Fotokjemisk fremgangsmåte til å innföre molekyler i cellers cytosol
MXPA03002413A (es) Moleculas tipo b7 y uso de las mismas.
AU2001290706A1 (en) Antisense modulation of clusterin expression
BR0210839A (pt) Sistema de recombinação, método para remover uma sequência de dna do dna cromossÈmico de uma célula ou organismo eucarióticos, organismo, cultura de célula, órgão, tecido, parte ou material de propagação transgênico, e, uso de um organismo ou de uma cultura de célula, órgão, tecido, parte ou material de propagação transgênico
WO2002036743A3 (en) Antisense modulation of calreticulin expression
AU5753598A (en) Novel genes coding for amino acid deacetylases with specificity for N-acetyl-L-phosphinothricin, their isolation and use
DK0923592T3 (da) Fremgangsmåder til rensning af nukleinsyrer
DE69636937D1 (de) Durch trans-spaltung erhaltene therapeutische molekule
EP2199299A3 (en) Antisense modulation of survivin expression
HK1047129A1 (en) Sequence-specific dna recombination in eukaryotic cells
HUP0402626A2 (hu) Vírus közreműködésével történő, a citoszolba irányuló molekulabevitelre szolgáló fotokémiai internalizáció és eljárás
WO2001029175A3 (en) Antisense modulation of fra-1 expression
EP1268507A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF THE TRANSCRIPTION FACTOR E2F-1
EP1250347A4 (en) ANTISENSE MODULATION OF THE AKT-3 EXPRESSION
MXPA03010728A (es) Moleculas de proteina-2 relacionadas con b7 y uso de las mismas.
WO2003056897A3 (en) Highly phosphorylated acid beta-glucocerebrosidase and methods of treating gaucher's disease
WO2003027229A3 (en) Antisense modulation of rip2 expression
WO2000061786A3 (en) Antisense modulation of pdk-1 expression
ATE301721T1 (de) In vivo herstellung von replicativen molekülen
AU6113098A (en) Compositions for treatment of disorders involving programmed cell death
WO2001012798A3 (en) Male sterile plants
WO2003033659A3 (en) Antisense modulation of matrix metalloproteinase 1 expression
WO2003050247A3 (en) Antisense modulation of mhc class ii transactivator expression
ATE295884T1 (de) Dna-expressionskonstrukt zur behandlung von infektionen mit leishmaniose
WO2002055535A3 (en) Antisense modulation of cytohesin-1 expression

Legal Events

Date Code Title Description
MK1K Patent expired